pemafibrate
Kowa Pharmaceuticals
['thanks']
pemafibrate fails to lower cvd risk in patients with high triglycerides: prominent the disappointing results are a blow to the triglyceride hypothesis: leading experts offer their take on what s next. thanks for the #aha22 story. 
Med journalist & editor @TCTMD; Editorial Director @CRFheart https://t.co/Rdwux5HeLO; bestselling author of The Quintland Sisters  https://t.co/75iGZAdymo. Trails, books, dogs.